Literature DB >> 6198742

Serum interferon levels and natural killer cell activity in patients with asbestosis.

S Kagamimori, M Watanabe, M Kubota, A Okada, K Yokoyama, K Nobutomo.   

Abstract

Natural killer cell activity and serum interferon levels were measured in 30 patients with asbestosis. The chest radiographs showed type 1 changes (ILO pneumoconiosis classification) in nine, type 2 changes in 19, and type 3 changes in two. Thirty control subjects matched for age, sex, and smoking habit were also studied. Patients with asbestosis had significantly higher serum interferon levels than the controls. There was no significant difference in natural killer cell activity between patients with asbestosis and normal controls.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6198742      PMCID： PMC459723          DOI： 10.1136/thx.39.1.65

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


  9 in total

Review 1.  Mechanisms of activation of human natural killer cells against tumor and virus-infected cells.

Authors:  D Santoli; H Koprowski
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

2.  Depression of viral interferon induction in cell monolayers by asbestos fibers.

Authors:  N Hahon; H L Eckert
Journal:  Environ Res       Date:  1976-02       Impact factor: 6.498

3.  Natural killer cell activity in systemic lupus erythematosus.

Authors:  K Oshimi; M Sumiya; N Gonda; S Kano; F Takaku
Journal:  Lancet       Date:  1979-11-10       Impact factor: 79.321

4.  Asbestos cancer: past and future hazards.

Authors:  J C Gilson
Journal:  Proc R Soc Med       Date:  1973-04

5.  Dual mechanism of interferon augmentation of natural killer cytotoxicity (NKCC).

Authors:  S Targan; F Dorey
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

Review 6.  Natural killer cells in the mouse: an alternative immune surveillance mechanism?

Authors:  R Kiessling; O Haller
Journal:  Contemp Top Immunobiol       Date:  1978

7.  Depression of natural killer cell activity by interferon.

Authors:  M Ho; L T White; H W Haverkos; M C Breinig; G J Pazin; J A Armstrong
Journal:  J Infect Dis       Date:  1981-12       Impact factor: 5.226

8.  Immune interferon in the circulation of patients with autoimmune disease.

Authors:  J J Hooks; H M Moutsopoulos; S A Geis; N I Stahl; J L Decker; A L Notkins
Journal:  N Engl J Med       Date:  1979-07-05       Impact factor: 91.245

9.  Depressed natural killer activity in rheumatoid arthritis and its in vitro augmentation with interferon and N-(2-carboxyphenyl)-4-chloroanthranilic acid disodium salt (CCA), an anti-arthritis agent.

Authors:  K Itoh; F Saitoh; K Kumagai; S Kosaka
Journal:  Ryumachi       Date:  1981
  9 in total
  2 in total

1.  Absence of immunoreactive interferon-alpha in CSF from patients with multiple sclerosis.

Authors:  R J Abbott; P D Giles; I Bolderson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-01       Impact factor: 10.154

2.  Asbestos fibres inhibit the in vitro activity of lymphokine-activated killer (LAK) cells from healthy individuals and patients with malignant mesothelioma.

Authors:  L S Manning; M R Davis; B W Robinson
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.